Lasmiditan Succinate Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Lasmiditan Succinate Tablet (tablet) from Eli Lilly and Co. with status To Be Discontinued. The shortage was first posted on 11/03/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Eli Lilly and Co.
- Package NDC
- 0002-4491-08
- Dosage Form
- Tablet
- Presentation
- Reyvow, Tablet, 100 mg (NDC 0002-4491-08)
- Initial Posting
- 11/03/2025
- Revised Date